Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomerica Inc (BMRA)

Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,960
  • Shares Outstanding, K 2,948
  • Annual Sales, $ 5,310 K
  • Annual Income, $ -4,970 K
  • EBIT $ -5 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.06
  • Price/Sales 1.47
  • Price/Cash Flow N/A
  • Price/Book 1.48

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.26 +19.47%
on 12/04/25
2.85 -5.26%
on 12/23/25
+0.38 (+16.38%)
since 11/26/25
3-Month
2.11 +27.96%
on 11/25/25
3.21 -15.97%
on 10/20/25
-0.11 (-3.91%)
since 09/26/25
52-Week
2.11 +27.96%
on 11/25/25
10.16 -73.43%
on 01/16/25
+0.10 (+3.85%)
since 12/26/24

Most Recent Stories

More News
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure. The $300 rate will apply to claims approved and paid...

BMRA : 2.70 (+1.89%)
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio

Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease,...

BMRA : 2.70 (+1.89%)
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE)...

BMRA : 2.70 (+1.89%)
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service Expansion Comprehensive CDMO services now featured on Biomerica’s updated website IRVINE, Calif., Nov....

BMRA : 2.70 (+1.89%)
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.

- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation’s Most Trusted Health Care Distributors - Relationship Marks a Key Milestone in Biomerica’s Commercialization...

HSIC : 76.13 (-0.08%)
BMRA : 2.70 (+1.89%)
Biomerica Reports First Quarter Fiscal 2026 Financial Results

Reported Improved Gross Margin from Contribution from Higher-Margin Product Mix Operating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company’s...

BMRA : 2.70 (+1.89%)
Biomerica Appoints Gary Huff to Board of Directors

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Biomerica...

BMRA : 2.70 (+1.89%)
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies...

BMRA : 2.70 (+1.89%)
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFoods ® IBS testing IBS affects an estimated 40 million adults in the U.S....

BMRA : 2.70 (+1.89%)
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use

10-minute home test detects early kidney damage in diabetic and hypertensive patients Hypertension affects roughly one-third of adults in the UAE Diabetes impacts approximately one in four UAE nationals...

BMRA : 2.70 (+1.89%)

Business Summary

BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include...

See More

Key Turning Points

3rd Resistance Point 3.02
2nd Resistance Point 2.91
1st Resistance Point 2.81
Last Price 2.70
1st Support Level 2.60
2nd Support Level 2.49
3rd Support Level 2.39

See More

52-Week High 10.16
Fibonacci 61.8% 7.08
Fibonacci 50% 6.13
Fibonacci 38.2% 5.19
Last Price 2.70
52-Week Low 2.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar